Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
Engage Therapeutics is a clinical stage pharmaceutical company with a deep-seated passion in epilepsy.
Lumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.
Adage Capital Management has invested in 76 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Adage Capital Management's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Health Diagnostics. The firm invests across 6 different industry categories.
Among tracked funding rounds, Aimmune Therapeutics received $200.0M in a Post Ipo Equity round. Adage Capital Management's total known invested capital is $11.1B.
Adage Capital Management's average investment size is $160.5M across its portfolio of 76 companies.
Recent Adage Capital Management portfolio additions include Aimmune Therapeutics. These companies were founded in 2020 or later.